Risk of death following application of paclitaxel‐coated balloons and stents in the femoropopliteal artery of the leg: a systematic review and meta‐analysis of …
Background Several randomized controlled trials (RCT s) have already shown that
paclitaxel‐coated balloons and stents significantly reduce the rates of vessel restenosis and …
paclitaxel‐coated balloons and stents significantly reduce the rates of vessel restenosis and …
Home-based cardiac rehabilitation: a scientific statement from the American Association of Cardiovascular and Pulmonary Rehabilitation, the American Heart …
Cardiac rehabilitation (CR) is an evidence-based intervention that uses patient education,
health behavior modification, and exercise training to improve secondary prevention …
health behavior modification, and exercise training to improve secondary prevention …
2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of …
G Mancia, R Kreutz, M Brunström, M Burnier… - Journal of …, 2023 - journals.lww.com
Document Reviewers: Luis Alcocer (Mexico), Christina Antza (Greece), Mustafa Arici
(Turkey), Eduardo Barbosa (Brazil), Adel Berbari (Lebanon), Luıs Bronze (Portugal), John …
(Turkey), Eduardo Barbosa (Brazil), Adel Berbari (Lebanon), Luıs Bronze (Portugal), John …
Transcatheter arterialization of deep veins in chronic limb-threatening ischemia
MH Shishehbor, RJ Powell… - … England Journal of …, 2023 - Mass Medical Soc
Background Approximately 20% of patients with chronic limb-threatening ischemia have no
revascularization options, leading to above-ankle amputation. Transcatheter arterialization …
revascularization options, leading to above-ankle amputation. Transcatheter arterialization …
JCS/JACR 2021 guideline on rehabilitation in patients with cardiovascular disease
S Makita, T Yasu, YJ Akashi, H Adachi, H Izawa… - Circulation …, 2022 - jstage.jst.go.jp
Eight years have passed since the publication of the only guideline on cardiac rehabilitation
(CR) in Japan,“Guidelines for rehabilitation in patients with cardiovascular disease (JCS …
(CR) in Japan,“Guidelines for rehabilitation in patients with cardiovascular disease (JCS …
Sex differences in peripheral artery disease
Peripheral artery disease (PAD) is a prevalent condition that confers substantial morbidity
and mortality and remains underdiagnosed as well as undertreated in the overall …
and mortality and remains underdiagnosed as well as undertreated in the overall …
Cardiovascular manifestations from therapeutic radiation: a multidisciplinary expert consensus statement from the International Cardio-Oncology Society
JD Mitchell, DA Cehic, M Morgia, C Bergom, J Toohey… - Cardio Oncology, 2021 - jacc.org
Radiation therapy is a cornerstone of cancer therapy, with> 50% of patients undergoing
therapeutic radiation. As a result of widespread use and improved survival, there is …
therapeutic radiation. As a result of widespread use and improved survival, there is …
[HTML][HTML] Diabetes and peripheral artery disease: A review
Peripheral arterial disease (PAD) refers to partial or complete occlusion of the peripheral
vessels of the upper and lower limbs. It usually occurs as part of systemic atherosclerosis in …
vessels of the upper and lower limbs. It usually occurs as part of systemic atherosclerosis in …
Effect of low-intensity vs high-intensity home-based walking exercise on walk distance in patients with peripheral artery disease: the LITE randomized clinical trial
Importance Supervised high-intensity walking exercise that induces ischemic leg symptoms
is the first-line therapy for people with lower-extremity peripheral artery disease (PAD), but …
is the first-line therapy for people with lower-extremity peripheral artery disease (PAD), but …
[HTML][HTML] Editor's choice--European Society for Vascular Surgery (ESVS) 2024 clinical practice guidelines on the management of asymptomatic lower limb peripheral …
J Nordanstig, CA Behrendt, I Baumgartner… - European Journal of …, 2024 - Elsevier
BIOTRONIK's First in Man study of the Passeo-18 LUX drug releasing PTA Balloon Catheter
vs. the uncoated Passeo-18 PTA balloon catheter in subjects requiring revascularisation of …
vs. the uncoated Passeo-18 PTA balloon catheter in subjects requiring revascularisation of …